These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
211 related articles for article (PubMed ID: 38234607)
1. The Potential and Application of iPSCs in Gene and Cell Therapy for Retinopathies and Optic Neuropathies. Lapshin EV; Gershovich YG; Karabelsky AV Acta Naturae; 2023; 15(4):56-64. PubMed ID: 38234607 [TBL] [Abstract][Full Text] [Related]
2. The use of induced pluripotent stem cells for studying and treating optic neuropathies. Khan S; Hung SS; Wong RC Curr Opin Organ Transplant; 2016 Oct; 21(5):484-9. PubMed ID: 27517502 [TBL] [Abstract][Full Text] [Related]
8. Hereditary Optic Neuropathies: A Systematic Review on the Interplay between Biomaterials and Induced Pluripotent Stem Cells. Ladero M; Reche-Sainz JA; Gallardo ME Bioengineering (Basel); 2024 Jan; 11(1):. PubMed ID: 38247929 [TBL] [Abstract][Full Text] [Related]
10. Therapeutic Strategies for Attenuation of Retinal Ganglion Cell Injury in Optic Neuropathies: Concepts in Translational Research and Therapeutic Implications. Fu L; Kwok SS; Chan YK; Ming Lai JS; Pan W; Nie L; Shih KC Biomed Res Int; 2019; 2019():8397521. PubMed ID: 31828134 [TBL] [Abstract][Full Text] [Related]
16. Dominant Optic Atrophy and Leber's Hereditary Optic Neuropathy: Update on Clinical Features and Current Therapeutic Approaches. Chun BY; Rizzo JF Semin Pediatr Neurol; 2017 May; 24(2):129-134. PubMed ID: 28941528 [TBL] [Abstract][Full Text] [Related]
17. Modeling autosomal dominant optic atrophy using induced pluripotent stem cells and identifying potential therapeutic targets. Chen J; Riazifar H; Guan MX; Huang T Stem Cell Res Ther; 2016 Jan; 7():2. PubMed ID: 26738566 [TBL] [Abstract][Full Text] [Related]
18. Progress in Gene Therapy to Prevent Retinal Ganglion Cell Loss in Glaucoma and Leber's Hereditary Optic Neuropathy. Ratican SE; Osborne A; Martin KR Neural Plast; 2018; 2018():7108948. PubMed ID: 29853847 [TBL] [Abstract][Full Text] [Related]
19. [Clinical characteristics and research progress on the treatment of mitochondrial optic neuropathy]. Guo ST; Jiang LB Zhonghua Yan Ke Za Zhi; 2021 May; 57(5):386-390. PubMed ID: 33915644 [TBL] [Abstract][Full Text] [Related]
20. Optic neuropathies: characteristic features and mechanisms of retinal ganglion cell loss. You Y; Gupta VK; Li JC; Klistorner A; Graham SL Rev Neurosci; 2013; 24(3):301-21. PubMed ID: 23612594 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]